ImmunityBio 通过1亿美元融资交易强化资产负债表,其中7500万美元为非稀释性融资,支持全球扩张及免疫疗法管线拓展

美股速递
Mar 31

ImmunityBio, Inc. 宣布完成总额达1亿美元的融资交易,显著增强公司财务结构。此次融资包含7500万美元的非稀释性资金,旨在为其全球市场扩张计划及更广泛的免疫疗法研发管线提供资金支持。该举措将助力公司推进创新疗法的开发,进一步巩固其在免疫治疗领域的领先地位。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10